Other Transaction Agreement W52P1J2192000
Award Date
5/25/21
Potential Completion Date
12/31/22
Potential Value
$100M
Funding Federal Agency
Joint PEO Chemical and Biological Defense
Contracting Federal Agency
Department of the Army
Awardee
Clinical Enterprise, LLC
Ultimate Awardee
Not listed
NAICS Category
Not listed
PSC Category
Q301 - Reference Laboratory Testing
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
Extent Competed
Competed
Major Defense Program
Not listed
Pricing Type
Other
Place of Performance
Framingham, MA 01702, USA
Solicitation Procedures
Broad Agency Announcement
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Department of the Army Acquisition Support Center Joint PEO Chemical and Biological Defense awarded a $12.8 million firm fixed price purchase order to Cepheid, a subsidiary of Danaher Corporation, for XPRSARS-COV2-10 TESTS. The contract is being funded by the Army to support the national interest in response to the Coronavirus COVID-19 and will provide Cepheid's coronavirus tests. Performance will occur in Sunnyvale, California over a 10 month period concluding in March 2021. No...
Battelle Memorial Institute, doing business as Battelle, was awarded a $93.4 million other transaction agreement by the Department of the Army Acquisition Support Center Joint PEO Chemical and Biological Defense to support the expansion of U.S. testing capacity using coordination hubs under project HU-2 Midwest. The contract will utilize coordination hubs to increase COVID-19 and other infectious disease testing capabilities across a multi-state region in the Midwest over an approximately...
The Department of the Army Acquisition Support Center Joint PEO Chemical and Biological Defense awarded a $41.2 million firm fixed price definitive contract to Cepheid, a subsidiary of Danaher Corporation, for the purchase of Cepheid GeneXpert Systems and COVID-19 assays. The contract supports the agency's response to the Coronavirus COVID-19 national interest by providing molecular diagnostic testing platforms and tests to detect SARS-CoV-2, the virus that causes COVID-19. Performance will take...
Revvity Health Sciences, Inc., a division of Revvity Inc. Medical Imaging, LLC, has been awarded a $66.2 million other transaction agreement by the Department of the Army Acquisition Support Center Joint PEO Chemical and Biological Defense to provide expansion of United States testing capacity using coordination hubs. Specifically, Hub 1 West will be established in Shelton, Connecticut under the contract running from May 2021 through December 2022. Key deliverables include coordinating...
The Department of the Army Acquisition Support Center Joint PEO Chemical and Biological Defense (DOD - Army - USASC) awarded a $6.5M firm fixed price delivery order contract to The Boston Consulting Group Inc., doing business as The Boston Consulting Group Inc., under its Multiple Award Schedule contract vehicle. The contract is for COVID-19 ACTION PROGRAM STRATEGY AND COMMUNICATION services to be performed at Fort Detrick, Maryland between September 30, 2022 and July 31, 2023. No applicable...
The Department of the Army Acquisition Support Center Joint PEO Chemical and Biological Defense awarded a $1.6 million firm fixed price delivery order to Cepheid, a subsidiary of Danaher Corporation. The order is for one year of service agreements to provide XPRSARS-COV2-DOD XPCOV2/FLU/RSV-10 GX44A1Y diagnostic testing platforms and associated support. Funding comes from the agency's budget to support coronavirus COVID-19 response as the primary national interest and program area. The period...
The Department of the Army Acquisition Support Center Joint PEO Chemical and Biological Defense awarded a $5.9 million firm fixed price delivery order to Biofire Defense LLC. The order is for the purchase of COVID-19 assays, external control materials, and software module updates to support the agency's response to the Coronavirus pandemic. Performance will take place in Salt Lake City, Utah, through December 2020. No set aside designation or subcontractors were indicated. The funding agency...
The Department of the Army Acquisition Support Center Joint PEO Chemical and Biological Defense awarded a $12 million firm fixed price delivery order to Cepheid, a subsidiary of Danaher Corporation, to support its XPCOV2/FLU/RSV-10 program. The contract calls for Cepheid to provide products and services for the detection of COVID-19, influenza, and respiratory syncytial virus from a single patient sample at its place of performance in Aberdeen, Maryland. The period of performance is from...
This definitive contract from the Department of the Army Acquisition Support Center Joint PEO Chemical and Biological Defense (JPEO-CBRND) awards Microbiologics, Inc. $13.6 million to deliver technology transfer of reporter VN assay in support of advanced SARS-CoV-2 medical countermeasure therapeutics. The solicitation sought proposals to manufacture and fill-finish a minimum of 100,000 treatment courses by March 2021 to treat the indicated U.S. population, with candidate therapeutics...
The Department of the Army Acquisition Support Center Joint PEO Chemical and Biological Defense awarded a $26.7 million other transaction agreement to America's Blood Centers 501C(6) Trade Association Division, doing business as ABC, to support the "COVID-19" PROTOTYPE PLASMA COLLECTION CAPABILITY. Under this contract, ABC will provide plasma collection services to the Army through October 2021. The work will be performed in West Warwick, Rhode Island. No set aside designation or...